Safe Pro Group Inc. SPAI

Healthcare SIC 3842 - Orthopedic, Prosthetic & Surgical Appliances & Supplies NAICS Manufacturing › Miscellaneous Manufacturing › Medical Equipment and Supplies Manufacturing › Surgical Appliance and Supplies Manufacturing derived Nasdaq

Pro Group Inc. was incorporated as a Delaware corporation in December 2021. Safe Pro Group was created to provide innovative security

and protection products and has strategically acquired and assembled three active business units focused on protecting those who protect

us all. Our strategic emphasis is on the development of a software-based ecosystem for analyzing drone imagery and data utilizing proprietary

artificial intelligence ("AI"), machine learning, deep learning, and applied computer vision software for hyper scalable

Last close 3.21 2026-10-23
Market cap $65.4M 2026-06-30 share count
52-week range 3.11 - 7.50

Valuation FY2025 figures against the last close

P/S107.7x
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-0.85

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022
Revenue $606.7K$2.2M$917.7K—
Cost of revenue $404.5K$1.3M$606.6K—
Gross profit $202.2K$906.1K$311.1K—
R&D $394.2K$90.4K$373.7K—
SG&A $2.1M$1.3M$449.9K—
Total operating expenses $14.7M$8.1M$6.6M—
Operating income -$14.5M-$7.2M-$6.3M—
Interest expense $12.8K$306.5K$8.2K—
Net income -$14.3M-$7.4M-$6.3M—
EPS, basic -0.85-0.70-0.79—
EPS, diluted -0.85-0.70-0.79—
Shares, diluted (wtd. avg.) 16.9M10.6M8.0M—

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022
Cash and equivalents $16.8M$2.0M$703.4K$1.8M
Receivables $100.0K$123.7K$163.3K—
Inventory $615.0K$342.1K$359.2K—
Total current assets $17.9M$2.8M$1.3M—
Property, plant and equipment $283.1K$314.9K$320.9K—
Goodwill —$684.9K$684.9K—
Other intangibles $834.5K$1.1M$987.3K—
Total assets $19.1M$4.9M$3.4M—
Accounts payable $461.3K$119.8K$169.1K—
Total current liabilities $1.3M$893.9K$1.4M—
Long-term debt $146.0K$146.0K——
Total liabilities $1.4M$1.1M$1.7M—
Retained earnings -$28.6M-$14.3M-$6.8M—
Total equity $17.7M$3.9M$1.8M$2.6M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022
Operating cash flow -$6.2M-$4.1M-$2.0M—
Depreciation and amortisation $381.3K$341.1K$239.0K—
Capital expenditure $48.8K$63.8K$30.2K—
Investing cash flow -$241.4K-$436.4K-$30.2K—
Financing cash flow $21.3M$5.8M$985.2K—

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001493152-26-020508.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -15M -10M -5M 0 5M Revenue, FY2023: 917.7K Gross profit, FY2023: 311.1K Net income, FY2023: -6.3M Revenue, FY2024: 2.2M Gross profit, FY2024: 906.1K Net income, FY2024: -7.4M Revenue, FY2025: 606.7K Gross profit, FY2025: 202.2K Net income, FY2025: -14.3M FY2022 FY2023 FY2024 FY2025
Fiscal year FY2022FY2023FY2024FY2025
Revenue — $917.7K $2.2M $606.7K
Gross profit — $311.1K $906.1K $202.2K
Net income — -$6.3M -$7.4M -$14.3M

Recent filings and events

  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Regulation FD disclosure Item 7.01
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Regulation FD disclosure Item 7.01
  • Regulation FD disclosure Item 7.01
  • Regulation FD disclosure Item 7.01
  • Regulation FD disclosure Item 7.01
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Results announced Item 2.02
  • Officer or director change Item 5.02
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Regulation FD disclosure Item 7.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 3842

TickerCompanyMarket capP/ERevenue growth
ISRG INTUITIVE SURGICAL INC $159.78B 57.5x 20.5%
EW Edwards Lifesciences Corp $51.34B 48.7x 11.5%
STE STERIS plc $22.63B 29.3x 8.7%
ZBH ZIMMER BIOMET HOLDINGS, INC. $18.80B 27.8x 7.2%
ALGN ALIGN TECHNOLOGY INC $10.98B 27.3x 0.9%
MSA MSA Safety Inc $7.03B 25.7x 3.7%
ESTA ESTABLISHMENT LABS HOLDINGS INC. $1.90B — 27.1%
CDRE Cadre Holdings, Inc. $1.28B 29.4x 7.5%